Skip to main content

Table 2 Analysis of NUCKS immunostaining in invasive breast carcinomas

From: NUCKS overexpression in breast cancer

Overall NUCKS immuno-
Reactivity
IDC, ILC, grade I
(n = 9)*
IDC, ILC, grade II
(n = 41)**
IDC, grade III
(n = 8)
Negative (0) 3 (33.5%) 4 (10%) 2 (25%)
+1 3 (33.5%) 9 (22%) 5 (62,5%)
+2 2 (22%) 12 (29%) 1 (12,5%)
+3 1 (11%) 16 (39%) 0
Low expression (0/+1) 6 (67%) 13 (32%) 7 (87,5%)
High expression (+2/+3) 3 (33%) 28 (68%) 1 (12,5%)
  1. * The 9 cases of grade I consisted of 8 IDC and 1 ILC
  2. * The 41 cases of grade II consisted of 35 IDC and 6 ILC